SELENOOLP: A Potential Drug Target and Biomarker for Selenoprotein O-like

Target Name: SELENOOLP

NCBI ID: G105376462

SELENOOLP

Other Name(s): Selenoprotein O like, pseudogene | selenoprotein O like, pseudogene

SELENOOLP: A Potential Drug Target and Biomarker for Selenoprotein O-like

Abstract:

Selenoprotein O-like (SELENOOLP) is a 21-kDa protein that is expressed in various tissues, including the brain, heart, and skeletal muscles. Despite its prevalence, the function and role of SELENOOLP in biological processes remain poorly understood. recent studies have identified SELENOOLP as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. In this article, we will review the current literature on SELENOOLP, including its expression and function, as well as its potential as a drug target and biomarker.

Introduction:

Selenoprotein O-like (SELENOOLP) is a 21-kDa protein that is expressed in various tissues, including the brain, heart, and skeletal muscles. SELENOOLP is composed of 126 amino acid residues and has a predicted localization in the cytoplasm. SELENOOLP is involved in various cellular processes, including cell adhesion, migration, and invasion.

Recent studies have identified SELENOOLP as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. In this article, we will review the current literature on SELENOOLP, including its expression and function, as well as its potential as a drug target and biomarker.

Expression and Function of SELENOOLP:

SELENOOLP is expressed in various tissues, including the brain, heart, and skeletal muscles. It is found in the endoplasmic reticulum (ER) and cytoplasm. SELENOOLP is involved in various cellular processes, including cell adhesion, migration, and invasion.

SELENOOLP plays a role in cell adhesion by interacting with cadherins, a transmembrane protein that is involved in cell-cell adhesion. SELENOOLP has been shown to interact with cadherins and regulate their activity. SELENOOLP has also been shown to be involved in cell migration and invasion, with studies showing that it is involved in the migration of cancer cells (6) and the invasion of immune cells.

Potential as a Drug Target:

SELENOOLP has been identified as a potential drug target due to its involvement in various cellular processes that are implicated in various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

One potential mechanism by which SELENOOLP could be targeted is its role in cell adhesion. neurodegenerative disorders, such as Alzheimer's disease, are characterized by the progressive loss of nerve cells, which is thought to be due to the dysfunction of cell adhesion. SELENOOLP has been shown to interact with cadherins and regulate their activity, which could make it a potential target for neurodegenerative disorders.

Another potential mechanism by which SELENOOLP could be targeted is its role in cancer progression. cancer cells have the ability to migrate and invade surrounding tissues, which is thought to be due to the dysfunction of cell adhesion. SELENOOLP has been shown to be involved in the migration of cancer cells and the invasion of immune cells, which could make it a potential target for cancer.

In addition to its potential as a

Protein Name: Selenoprotein O Like, Pseudogene

The "SELENOOLP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SELENOOLP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets